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Background: ERAS (Enhanced Recovery After Surgery) 
protocol is a multimodal pathway of perioperative 
surgical care consisting of evidence-based procedures. 
ERAS protocol is hard to comply with, because medical 
staff often opposes well established practice.
Methods: We analyzed length of hospital stay, 
postoperative complications, time until first stool 
passage and introduction of normal nutrition in patients 
undergoing elective colorectal resection surgery in 
University Hospital Center Split from October 2016. 
to October 2018. Patients were divided into 4 groups 
considering operation type (open/laparoscopic) and 
application of ERAS protocol (good/poor). Application 
of 60% or more ERAS steps was considered as well 
performed protocol. 
Results: Groups Laparoscopy/ERAS and Open/ERAS 
had shorter postoperative hospital stay (Median, IQR; 
days) than groups Laparoscopy/non-ERAS and Open/
non-ERAS (LE 5, 4-8 , OE 6, 5-9 vs LNE 7, 5-8,5 , ONE 7, 
6-12). Similar difference was shown in times until first 
stool passage. Patients operated laparoscopically had 
shorter times until normal food tolerance (Median, 
IQR; days): LE 3, 2-3, LNE 3, 2-4 than patients who 
underwent open surgery (OE 3, 3-4, ONE 4, 3-5). In 
addition, laparoscopically operated patients had lower 
overall morbidity (P<0.001). Incidence of unplanned 
operations and hospital readmissions did not differ 
significantly among groups.
Conclusion: Well-performed ERAS protocol can 
improve length of hospital stay and time until first 
stool passage in both open and laparoscopic types of 
operation. Optimal combination for colorectal resection 
is laparoscopic surgery with ERAS protocol. If open 
surgery is done, it should be preferably applied with 
ERAS protocol as well.
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INTRODUCTION 
ERAS (Enhanced Recovery After Surgery) is a multimodal, 
evidence based protocol of perioperative care. The goal 
of this modality, introduced by Kehlet in early 1990´s, 
is to standardize perioperative care and combine many 
scientifically proven steps in order to reduce the length 
of perioperative stay, surgical stress and number of 
complications. This way, patient is back in the centre of 
care rather than individual decisions of a surgeon and 
other medical staff [1-27]. ERAS protocol in University 
Hospital Center Split was first introduced in October 
2016.
MATHERIALS AND METHODS
Study population and exclusion criteria.
We collected data from a longitudinal, prospective 
cohort of patients at Department of surgery in 
University Hospital Center Split in two years period 
following introduction of ERAS protocol (October 2016. - 
October 2018.). Only the patients that fulfilled following 
criteria were included: 1) Pathohistological evidence of 
malignant disease before hospital admission, 2) Elective 
colorectal resection surgery was indicated as curative 
therapy of choice, 3) Patients were part of ERAS protocol 
with predefined discharge criteria.
The exclusion criteria were following: 1) History of 
major abdominal operation, 2) History of any operation 
30 days before colorectal resection, 3) ASA score >3, 4) 
Disseminated (metastatic) disease. Every patient was 
followed three months after day of hospital discharge. 
All patients were informed about ERAS protocol and 
agreed to participate in study.
Group formation
Group formation was based on compliance of ERAS 
protocol (60% or more steps applied were considered 
as well performed ERAS protocol) and type of operation 
(open or laparoscopic). Consequently, we divided 
patients into four groups: Open/non-ERAS (open 
operations and poorly performed ERAS) or „ONE“, Open/
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ERAS (open operations and well performed ERAS) or 
„OE“, Laparoscopy/non-ERAS (laparoscopic operations 
and poorly performed ERAS) or „LNE“ and Laparoscopy/
ERAS (laparoscopic operations and well performed 
ERAS) or „LE“ (Figure 1). 
Baseline characteristics
For every patient basic set of information (age, 
gender, BMI, body fat percentage, haemoglobin levels, 
ASA stage, consumption of tobacco and alcohol, 
comorbidities), diagnostic workup (cancer site and 
staging,) and operation data (type, duration, presence 
of stoma, amount of fluid given during operation) were 
collected.
ERAS steps
We followed application of 20 ERAS steps in total (8 
preoprative, 4 intraoperative and 8 postoperative). ERAS 
step was considered applied only when it fulfilled strict 
criteria. All criteria were based on prominent clinical 
studies and recommendations as shown in Table 1.
Outcomes
Primary outcomes were length of postoperative 
hospital stay, time of return of bowel function (day of 
first stool passage and introduction of normal nutrition). 
All patients were discharged when they complied with 
these hospital discharge criteria: (1) tolerance of oral 
intake of fluids and food, (2) passage of first stool, (3) 
absence of nausea, (4) pain that can be controlled with 
oral analgesics and (5) patient´s consent.
Secondary outcomes were incidence of major and minor 
complications, unplanned reoperations, readmissions 
and in-hospital mortality.
Statistical analysis
For continuous data we tested normality of distribution 
(Shapiro-Wilk test) and homogeneity of variance 
(Levene´s test). We expressed our data as arithmetic 
mean ± standard deviation, median with interquartile 
range, minimum and maximum value where 
appropriate. In inferential statistics we used Analysis 
of Variance (ANOVA-test) and Kruskal Wallis with 
Mann-Whitney U test. For categorical data we used 
Chi-squared (χ2) test. Significance level was set at 5% 
(P<0.05). Statistics were made using software IBM SPSS 
Statistics 25.0., Chicago, Illinois, USA. 
RESULTS
Baseline characteristics
We compared baseline characteristics among groups 
as seen in Table 2. There were statistically significant 
differences in haemoglobin and body fat percentage 
values. In surgical aspects there were significant 
differences in types of resection and presence of 
stoma between open and laparoscopic groups. When 
we compared types of surgical resections and stoma 
presence in open and laparoscopic groups separately 
they did not differ significantly.
ERAS steps compliance
We noted 20 ERAS steps in total and compared number 
of applied steps in each group. In „Open ERAS“ group 
13,26±1,35 out of the 20 steps and in „Laparoscopic 
ERAS“ group 14,15±1,57 per person was applied. In 
groups with poorly performed ERAS some of the steps 
were also applied. In „Open non-ERAS“ group 10,04± 
1,11 and in „Laparoscopic non-ERAS“ 8,79±1,85 was 
applied successfully (Table 3).
Primary outcomes
Length of postoperative hospital stay was significantly 
shorter in patients operated laparoscopically with 
well performed ERAS (LE) comparing to other three 
groups. On the other hand, patients that underwent 
open surgery with poorly performed ERAS (ONE) had 
statistically significant longer postoperative stay than 
patients in other three groups. Group Open/ERAS (OE) 
had shorter postoperative stay than Laparoscopy/non-
ERAS (LNE), but without statistical significance. Similarly, 
group Laparoscopy/ERAS (LE) had significantly shorter 
time until first stool passage than other three groups. 
Group Open /ERAS (OE) had shorter time until first stool 
passage than both groups with poorly performed ERAS, 
but only difference in comparison to group Open/non-
ERAS (ONE) was statistically significant. When analysing 
time until normal food introduction, patients operated 
laparoscopically (groups LE and LNE) tolerated this 
kind of food earlier. However, the difference between 
Laparoscopy/non-ERAS (LNE) and Open/ERAS (OE) 
was not statistically significant. Open/non-ERAS (ONE) 
group had significantly longer time until normal food 
introduction in comparison with other three groups 
(Table 4).
Secondary outcomes
There was significant difference in overall morbidity 
and major complications when comparing laparoscopic 
(LNE and LE) and open (OE and ONE) groups (P<0,001) 
as illustrated in Table 5. Open/ERAS (OE) group showed 
lower overall morbidity and less major complications 
when comparing to Open/non-ERAS (ONE) group, but 
without statistical significance. Similarly, „Laparoscopic 
ERAS“ showed better overall morbidity with less major 
complications than „Laparoscopic non-ERAS group“, but 
also without statistical significance.
DISCUSSION
Our study showed that combination of laparoscopic 
surgery and ERAS protocol (group LE) enables 
significantly faster postoperative recovery (length 
of postoperative hospital stay, time until first stool 
passage and induction of normal nutrition) than all 
three other combinations. Group Open/ERAS (OE) had 
significantly faster postoperative recovery than group 
Open/non-ERAS (ONE) and very similar results as group 
Laparoscopy/non-ERAS (LNE). More precisely, group OE 
had shorter length of postoperative stay and time until 
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first stool passage than group LNE, but without statistical 
significance. Patients in group Open/non-ERAS (ONE) 
had significantly prolonged postoperative recovery in 
comparison to all three other groups. Morbidity was 
significantly lower in patients operated laparoscopically 
(groups LE and LNE). There was no statistically significant 
difference in unplanned reoperations, readmissions 
and in-hospital mortality among groups. In this 
category ERAS protocol had smaller influence than in 
postoperative recovery. However, group Open/ERAS 
(OE) had lower overall morbidity and lower incidence of 
unplanned reoperations and readmissions in comparison 
to group Open/non-ERAS (ONE), but without statistical 
significance. Length of postoperative hospital stay as 
well as overall morbidity is similar to results given in 
prominent meta-analyses [27-29]. However, incidence of 
complications shown in our study is mostly higher than 
results published in meta-analyses. It can be explained 
by non-existing upper age limit in our study. Length 
of postoperative hospital stay was almost equal to 
prominent LAFA-study by Vlug et al. [30]. Although, when 
comparing times until first stool passage and normal food 
tolerance, LAFA study showed much better results. This 
could be partially explained with fact that we included 
patients with planned stoma formation (colostoma and 
ileostoma). Designs of ERAS studies differ dramatically. 
Therefore, comparison among papers is extremely 
difficult [27]. Some studies only include operations of the 
colon without rectum [31-36] or only laparoscopically 
operated patients [31, 37-44] Also, number and type of 
ERAS steps applied is different in almost every study [27]. 
Systematic review of Messenger et al. precisely described 
mentioned variability by publishing range of 6 to 21 
steps applied among 34 analyzed studies [45]. Moreover, 
it is rarely seen that authors describe exact criteria that 
they used when deciding which ERAS step was applied. 
We explained every ERAS step individually with adequate 
reference, hoping that future studies will also provide this 
kind of information. Strength of this study is thoroughly 
described compliance for every ERAS step. This set of 
information could help discovering which ERAS step is 
more important in the future. Studies rarely report this 
result which was mentioned in systematic review by 
Messenger et al. They noted that only one of all analyzed 
RCTs reported this kind of data [45]. We conducted audit 
in accordance to systematic reviews and meta-analysis 
who constantly pointed out weaknesses of analyzed 
studies [27-29, 45]. In order to enable easier comparison 
in the future we also followed audit guidelines of ERAS® 
society [46]. Limitation of this study is it´s sample size. 
Moreover, groups are unbalanced in number and in 
some basic characteristics. Group Laparoscopy/ERAS 
(LE) had significantly higher level of preoperative 
haemoglobin and body fat percentage than group 
Open/non-ERAS (ONE). Body fat percentage is easily 
explained with higher percentage of females but higher 
haemoglobin levels remain unexplained. Some types 
of operations were more common in laparoscopic and 
some in open type of surgery. It is very hard to say which 
operation is more severe so the influence of this kind of 
data is unknown. Except types of operation, presence of 
stoma was also significantly different when comparing 
laparoscopic and open surgery. Stomas were more 
common in laparoscopic surgery. Presence of stoma is 
linked with worse outcomes, especially regarding stool 
passage, which could explain why patients in group 
OE needed less time to achieve this goal than patients 
in group LNE [47]. Unbalanced group sizes and usage 
of nonparametric tests in our inferential statistics have 
lowered the strength and therefore significance in given 
results could be exaggerated. On the other hand, still 
relatively low overall compliance and small difference 
in compliances between ERAS and non-ERAS groups 
could underestimate it [48,49]. In our study, all patients 
were part of ERAS protocol, planned to achieve as many 
steps as possible. That explains smaller difference in 
compliance between well and poorly performed ERAS 
groups. We can say that type of operation and ERAS 
compliance are two most important predictors of surgical 
outcomes. At the end, we can state that ERAS protocol 
is a type of perioperative care that will lead to better 
outcomes in almost every parameter analyzed. Some of 
the results did not show statistical significance, but we 
should consider that even unsignificant differences can 
provide substantial clinical benefit.
CONCLUSION
Our study showed that well performed ERAS protocol 
can reduce length of postoperative hospital stay and 
time until first stool passage. The best combination 
to use when performing colorectal surgery is 
laparoscopy with well performed ERAS protocol. ERAS 
is also recommended type of perioperative care in 
combination with open surgery.
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Figure 1. Study flow 
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ERAS STEP    EVIDENCE BASED CRITERIA
1.   Preoperative counselling  Patient is familiar with ERAS steps, expectations, type of operation and  
     risks (3,4).
2.   Preoperative nutritional screening Calculating NRS 2002 score at least two weeks before day of operation. 
     Patients with 3 points or more are scheduled for nutritional  
     intervention with high-protein drinks (5).
3.   Bowel preparation   For operations with total mesorectal excision polyethylene glycol  
     is used afternoon before operation and enema morning before  
     operation. For other operations no bowel preparation is used (6,7).
4.   Preoperative fasting treatment  Patients are allowed to take solid food up to 6 hours and clear fluids up 
     to 2 hours before induction of anaesthesia (8,9).
5.   Preoperative carbohydrate treatment Patients should ingest >100g of carbohydrates afternoon before and  
     >50g morning before the operation (10).
6.   Antibiotic prophylaxis   First generation cephalosporin (cefazolin) and metronidazole are given 
     intravenously 60 minutes before skin incision (11,12).
7.   Antithrombotic prophylaxis  Usage of compression socks or intermittent pneumatic compression  
     with low-molecular heparin (13,14).
8.   Preanesthetic medication  Routine usage of enteral sedative drugs is avoided. If needed, usage of  
     5 mg diazepam intravenously is allowed (15).
9.   Anaesthetic protocol   Combination of general and regional anesthetics with rapid  
     awakening is used (15).
10. Prevention of intraoperative   Patients are warmed under a blanket during procedure with 
       hypothermia    temperature maintained at 34°C (16).
11. Intraoperative fluid management 1-4 mL/kg/h of crystalloid fluid is used for open and laparoscopic  
     surgery (17).
12. Application of nasogastric tube Routine application as ileus and vomiting prevention should be  
     avoided (18-20).
13. Abdominal drainage   All abdominal drains are removed in first three days after operation. 
14. PONVa prophylaxis   For patients with low/mild risk dexamethasone (4-8 mg) with  
     or without metoclopramide (10 mg) is administered. For patients with  
     high risk ondansetron/granisetron is administered (22,23).
15. Postoperative analgesia  Avoidance of opioid analgesics and usage of NSAIDs, paracetamole,  
     metamizole and epidural analgesia (15, 22).
16. Signs of ileus check   Signs of ileus are checked every day. 
17. Intake of fluid on the day of operation Patient should drink (not more than 800 mL) of fluid afternoon after  
     the procedure (23).
18. Early ambulation   Patients are mobilized to sit at the end of the bed or get up and walk  
     short distances (15, 24).
19. High protein ONSb intake  Patients need to take high-protein drinks first four days after the  
     operation (15,25).
20. Urinary drainage management  Urinary catheter is removed in first two days after the operation (26).
a Prophylaxis Of Nausea and Vomiting
b Oral Nutrition Supplement
  
Table 1. ERAS steps and criteria
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    Laparoscopy  Open and Laparoscopy Open  P 
    and ERAS  ERAS  non-ERAS non-ERAS 
    (LE)  (OE)  (LNE)  (ONE)
    N=60  N=54  N=23  N=126 
  
Age (AM±SDa, year)  66,63  67,23  68,17  68,86  0,451*
Gender (M/F)   31/29  35/19  14/9  91/35  0,051†
BMIb (AM±SD, kg/m2)  26,89  25,96  27,05  26,55  0,584*
Body fat (AM±SD, %)  26,77  24,81  26,35  23,43  0,030*
Preoperative haemoglobin 131,25  121,74  130,35  125,98  0,037* 
(AM±SD, g/L)
Duration of procedure median 135 (117,5-165) 100 (70-130) 140 (120-155) 100 (80-122,5) <0,001‡ 
(IQRc, min)
Fluids given during procedure   1000 (800-1250) 1000 (800-1300) 1050 (1000-1600) 1100 (1000-1500) 0,110‡ 
median (IQR, mL)
ASAd, N (%)           0,576†
I    2 (3,33)  2 (3,7)  0 (0)  3 (2,38) 
II    44 (73,3) 34 (62,96) 18 (78,26) 79 (62,70) 
III    14 (23,33) 18 (33,33) 5 (21,74) 44 (34,92) 
Comorbiditiese     
Total, N    54  42  22  118  0,734†
Patients with one or more  39 (65,00) 32 (59,26) 17 (73,91) 82 (65,08) 0,668† 
comorbidities, N (%)
Tobacco, N (%)   8 (14,55) 6 (11,32) 4 (19,05) 24 (19,51) 0,535†
Alcohol, N (%)   1 (1,82)  2 (4,08)  1 (4,55)  5 (4,07)  0,862†
Type of colectomy, N (%)     
Ileocecal resection  2 (3,33)  1 (1,85)  0 (0)  1 (0,79) 
Right hemicolectomy  0 (0)  24 (44,44) 0 (0)  45 (35,71) 
Transversotomy   0 (0)  1 (1,85)  0 (0)  2 (1,59) 
Left hemicolectomy  0 (0)  2 (3,70)  0 (0)  8 (6,35) 
Sigmoidectomy   4 (6,67)  7 (12,96) 1 (4,35)  13 (10,32) 
Hartmann resection  5 (8,33)  8 (13,33) 2 (3,33)  4 (3,17) 
Lower anterior resection  38 (63,33) 9 (16,67) 15 (65,22) 41 (32,54) 
Quenn-Milles   9 (15,00) 2 (3,70)  5 (21,74) 9 (7,14) 
(Abdominoperineal resection)
En bloc resections  0 (0)  0 (0)  0 (0)  1 (0,79) 
Total/subtotal colectomy  0 (0)  0 (0)  0 (0)  1 (0,79) 
Otherf    2 (3,33)  0 (0)  0 (0)  1 (0,79) 
Presence of stoma, N (%)  23 (38,33) 11 (20,37) 7 (30,43) 20 (15,87) 0,006†
T-Stage, N (%)           0,284†
Tis    0 (0)  0 (0)  1  (5,26)  0 (0) 
T1    7 (14,29) 2 (3,92)  2 (10,53) 6 (5,13) 
T2    13 (26,53) 10 (19,61) 3 (15,79) 22 (18,80) 
T3    22 (44,90) 28 (54,90) 9 (47,37) 72 (61,54) 
T4    7 (14,29) 11 (21,57) 4 (21,05) 17 (14,53) 
N-Stage, N (%)           0,613†
N0    33 (67,35) 32 (62,75) 13 (68,42) 83 (70,94) 
N1    9 (18,37) 14 (27,45) 5 (26,32) 27 (23,08) 
N2    7 (14,29) 5 (9,80)  1 (5,26)  7 (5,98) 
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Acta Chirurgica Croatica 
a Arithmetic Mean±Standard Deviation
b Body Mass Index
c Interquartile range
d American Society of Anesthesiologists
e Hypertension, diabetes type II, COPD, liver cirrhosis, heart failure, history of myocardial infarction and/or CVI, other  
  neurological diseases e.g. epilepsy, mb. Parkinson
f Transanal total mesorectal excision (TaTME), segmental resections
* Analysis of variance (ANOVA-test)
† Chi-squared test
‡ Kruskal-Wallis test
Table 2. Baseline characteristics and surgical aspects per group
 
ERAS STEPS, N (%)   Laparoscopy Open and Laparoscopy Open   
     and ERAS  ERAS  non-ERAS non-ERAS 
     (LE)   (OE)  (LNE)  (ONE) 
     N=60  N=54  N=23  N=126
  
Preoperative counselling   49 (81,67) 36 (66,67) 11 (47,83) 45 (35,71)
Preoperative nutritional screening  29 (48,33) 21 (38,89) 1 (4,35)  17 (13,49) 
and intervention
Bowel preparation   55 (91,67) 45 (83,33) 11 (47,83) 58 (46,03)
Preoperative fasting treatment  58 (96,67) 52 (96,30) 13 (56,52) 62 (49,21)
Preoperative carbohydrate treatment 47 (78,33) 47 (87,04) 12 (53,17) 64 (50,79)
Antibiotic prophylaxis   60 (100)  54 (100)  23 (100)  124 (98,41)
Antithrombotic prophylaxis  59 (98,33) 54 (100)  20 (86,96) 113 (89,68)
Preanesthetic medication   5 (8,33)  3 (5,55)  1 (4,35)  11 (8,73)
Anaesthetic protocol   35 (58,33) 39 (72,22) 12 (53.17) 62 (49,21)
Prevention of intraoperative hypothermia 23 (38,33) 19 (35,19) 4 (17,39) 25 (19,84)
Intraoperative fluid management  0 (0)  0 (0)  0 (0)  0 (0)
Application of nasogastric tube  59 (98,33) 53 (98,15) 22 (95,65) 113 (89,68)
Abdominal drainage   39 (65,00) 26 (48,15) 4 (17,39) 9 (7,14)
PONV prophylaxis   28 (46,67) 15 (27,78) 4 (17,39) 13 (10,32)
Postoperative analgesia   49 (81,67) 47 (87,04) 16 (69,57) 64 (50,79)
Signs of ileus check   59 (98,33) 54 (100)  23 (100)  125 (99,21)
Intake of fluid on the day of operation 37 (61,67) 31 (57,41) 10 (43,48) 49 (38,89)
Early ambulation    53 (88,33) 34 (62,96) 13 (56,52) 41 (32,54)
High protein ONS intake   54 (90,00) 49 (90,74) 19 (82,61) 91 (72,22)
Urinary drainage management  51 (85,00) 37 (68,52) 12 (52,17) 21 (16,67)
TOTAL, AM±SD    14,15±1,57 13,26±1,35 10,04±1,11 8,79±1,85
    
Table 3. Protocol compliance
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Acta Chirurgica Croatica  
Length of postoperative hospital stay, days    LE OE LNE ONE
GROUP    Median (IQR)a  Minb Maxc P<0,001*
Laparoscopy and ERAS  
(LE)    5 (4-6)   2 23 / 0,001 0,001 <0,001 
N=60    
Open and ERAS  
(OE)     6 (5-9)   3 16 0,001 / 0,374 <0,001 
N=54 
Laparoscopy non-ERAS 
(LNE)     7 (5-8,5)   5 19 0,001 0,374 / 0,034 
N=23 
Open non-ERAS  
(ONE)     7 (6-12)   4 25 <0,001 <0,001 0,034 / 
N=126 
Day of first stool passage      LE OE LNE ONE
GROUP    Median (IQR)  Min Max P<0.001*
Laparoscopy and ERAS  
(LE)    3 (2-4)   1 10 / 0,004 <0,001 <0,001 
N=60 
Open and ERAS  
(OE)    4 (3-5)   1 9 0,004 / 0,077 0,011 
N=54 
Laparoscopy non-ERAS  
(LNE)    5 (4-6,5)   2 8 <0,001 0,077 / 0,269 
N=23 
Open non-ERAS  
(ONE)    4 (3-5)   1 14 <0,001 0,011 0,269 / 
N=126 
Day of normal food introduction      LE OE LNE ONE
GROUP    Median (IQR)  Min Max P<0,001*
Laparoscopy and ERAS  
(LE)    3 (2-3)   1 5 / <0,001 0,070 <0,001 
N=60 
Open and ERAS  
(OE)    3 (3-4)   2 7 <0,001 / 0,077 <0,001 
N=54 
Laparoscopy non-ERAS  
(LNE)    3 (2-4)   1 5 0,070 0,077 / <0,001 
N=23 
Open non-ERAS  
(ONE)    4 (3-5)   2 14 <0,001 <0,001 <0,001 / 
N=126 
a Median (Interquartile range)
b Minimal value
c Maximal value
* Kruskal-Wallis test. Groups were individually compared by Mann-Whitney U test
Table 4. Primary outcomes
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Acta Chirurgica Croatica 
    Laparoscopy  Open  Laparoscopy Open  P* 
    and ERAS  and ERAS non-ERAS non-ERAS 
    (LE)  (OE)  (LNE)  (ONE) 
    N=60  N=54  N=23   N=126
   
Overall morbidity   20 (33,33) 38 (70,37) 9 (39,13) 92 (73,02) <0,001 
< 30 days, N (%)  
Patients with one or more  4 (6,67)  15 (27,78) 3 (13,04) 51 (40,48) <0,001 
major complication, N (%)
Total no. of major complications 5  15  4  59 
   Pathological ileus  3   15  3  45 
   Anastomotic leakage  1  0  0  5 
   Anastomotic fistula  1  0  0  2 
   Wound dehiscence  0  0   0  2 
   Peritonitis   0  0  0  1 
   Intraabdominal abscess  0  0  0  2 
   Haemoperitoneum  0  0  0  1 
   Othera   0  0  1  1 
Patients with one or more  16 (26,67) 23 (42,59) 6 (26,09) 41 (32,54) 0,278 
minor complication, N (%)
Total no. of minor complications 17  28  6  46 
   Wound infection  6  13  3  23 
   Wound haematoma  0  1  0  1 
   Urinary tract infection  2  4  0  5 
   Pneumonia   0  1  0  1 
   Nausea and vomiting  7  6  2  13 
   Otherb   2  3  1  3 
Unplanned reoperations, N (%) 3 (5,00)  2 (3,70)  1 (4,35)  13 (10,32) 0,375
Total no. of readmissions, N (%) 3 (5,00)  1 (1,85)  0 (0)  6 (4,76)  0,568
< 1 month   3  1  0   5 
< 3 months   0   0   0  1 
In-hospital mortality, N (%) 0 (0)  0 (0)  0 (0)  0 (0) 
a Necrosis of skin around stoma
b Blood in stool
* Chi-squared test
Table 5. Secondary outcomes
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